Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Journal of Asian Natural Products Research|April 28, 2017
Fusaripeptide A: new antifungal and anti-malarial cyclodepsipeptide from the endophytic fungus Fusarium spSabrin R M Ibrahim, Hossam M Abdallah, Ehab S Elkhayat, et al.Zeitschrift Fur Naturforschung. C, Journal of Biosciences|November 9, 2017
Mangostanaxanthone VII, a new cytotoxic xanthone from Garcinia mangostanaSabrin R M Ibrahim, Gamal A Mohamed, Mahmoud A Elfaky, et al.BMC Cancer|October 6, 2025
Novel anticancer effect of substituted imidazole derivatives against urothelial carcinoma: integrating In vitro screening and molecular docking for target kinasesBasma Emad Aboulhoda, Abdelsattar M Omar, Sara Elfarrash, et al.Future Medicinal Chemistry|November 12, 2024
New immunomodulatory anticancer quinazolinone-based thalidomide analogs: design, synthesis and biological evaluationMaged Mohammed Saleh Al Ward, Abdallah E Abdallah, Mohamed F Zayed, et al.Bioorganic Chemistry|December 12, 2017
Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agentsHany E A Ahmed, Saleh K Ihmaid, Abdelsattar M Omar, et al.Bioorganic & Medicinal Chemistry|January 11, 2018
Fusarithioamide B, a new benzamide derivative from the endophytic fungus Fusarium chlamydosporium with potent cytotoxic and antimicrobial activitiesSabrin R M Ibrahim, Gamal A Mohamed, Rwaida A Al Haidari, et al.Journal of Medical Imaging and Radiation Oncology|March 6, 2014
Fallopian tube recanalisation using dedicated radiographic tubal assessment set in angiography suiteMh Al-Omari, A Al-Mnayyis, N Obeidat, et al.Bioorganic Chemistry|May 9, 2017
Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitorsSaleh Ihmaid, Hany E A Ahmed, Adeeb Al-Sheikh Ali, et al.International Journal of Molecular Sciences|August 12, 2023
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide AnalogsReda R Mabrouk, Abdallah E Abdallah, Hazem A Mahdy, et al.Journal of Clinical Pharmacology|July 3, 2026
New Insights into Genetic Polymorphisms Influencing the Therapeutic Efficacy and Toxicity of RivaroxabanMohammad Salem Hareedy, Hayan W Mubaideen, Dana O Al Tarawneh, et al.Pageof 9